Skip to main content
NCBI home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;16(1):80–85. doi: 10.1111/j.1750-3639.2006.tb00564.x

Modeling Familial British Dementia in Transgenic Mice

Fiona Pickford 1,4, Janaky Coomaraswamy 2,3, Mathias Jucker 2,3, Eileen McGowan 1,✉
PMCID: PMC8095845  PMID: 16612985

Abstract

The chromosome 13 linked amyloidopathies familial British dementia (FBd) and familial Danish dementia (Fdd) are caused by mutations in the c‐terminus of the BRI2 gene. In both diseases, novel peptides are deposited in amyloid plaques in the brain. several laboratories have attempted to model these diseases in BrI2 transgenic mice with limited success. While high expression levels of BRI protein were achieved in transgenic lines, no aBri‐amyloidosis was observed in aged mice. this review discusses the strategies chosen and problems experienced with the development of FBd/Fdd models and suggests novel approaches to model the diseases in murine models.

References

  • 1.Akiyama H, Kondo H, Arai T, Ikeda K, Kato M, Iseki E, Schwab C, McGeer PL (2004) Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brain. Acta Neuropathol (Berl) 107:53–58. [DOI] [PubMed] [Google Scholar]
  • 2.Borchelt DR, Davis J, Fischer M, Lee MK, Slunt HH, Ratovitsky T, Regard J, Copeland NG, Jenkins NA, Sisodia SS, Price DL (1996) A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal 13:159–163. [DOI] [PubMed] [Google Scholar]
  • 3.Calhoun ME, Burgermeister P, Phinney AL, Stalder M, Tolnay M, Wiederhold KH, Abramowski D, Sturchler‐Pierrat C, Sommer B, Staufenbiel M, Jucker M (1999) Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA 96:14088–14093. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Chishti MA, Yang DS, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J, Turner S, Lozza G, Grilli M, Kunicki S, Morissette C, Paquette J, Gervais F, Bergeron C, Fraser PE, Carlson GA, George‐Hyslop PS, West‐away D (2001) Early‐onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276:21562–21570. [DOI] [PubMed] [Google Scholar]
  • 5.Drews R, Paleyanda RK, Lee TK, Chang RR, Rehemtulla A, Kaufman RJ, Drohan WN, Lubon H (1995) Proteolytic maturation of protein C upon engineering the mouse mammary gland to express furin. Proc Natl Acad Sci USA 92:10462–10466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.El‐Agnaf OM, Nagala S, Patel BP, Austen BM (2001) Non‐fibrillaroligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils. J Mol Biol 310:157–168. [DOI] [PubMed] [Google Scholar]
  • 7.Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie, F (1995) Alzheimer‐type neuropathology in transgenic mice overexpressing V717F beta‐amyloid precursor protein Nature 373:523–527. [DOI] [PubMed] [Google Scholar]
  • 8.Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM (2002) Neuronal alpha‐synucleinopathy with severe movement disorder in mice expressing A53T human alpha‐synuclein. Neuron 34:521–533. [DOI] [PubMed] [Google Scholar]
  • 9.Goate A, Chartier‐Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, et al (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349:704–706. [DOI] [PubMed] [Google Scholar]
  • 10.Guenette SY, Tanzi RE (1999) Progress toward valid transgenic mouse models for Alzheimer's disease. Neurobiol Aging 20:201–211. [DOI] [PubMed] [Google Scholar]
  • 11.Hashimoto M, Rockenstein E, Masliah E (2003) Transgenic models of alpha‐synuclein pathology: past, present, and future. Ann N Y Acad Sci 991:171–188. [PubMed] [Google Scholar]
  • 12.Herzig, MC. Winkler, DT. Burgermeister, P. Pfeifer, M. Kohler, E. Schmidt, SD. Danner, S. Abramowski, D. Sturchler‐Pierrat, C. Burki, K. van Duinen, SG. Maat‐Schieman, ML. Staufenbiel, M. Mathews, PM. Jucker, M (2004) Abeta is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 7:954–960. [DOI] [PubMed] [Google Scholar]
  • 13.Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K (1998) Accelerated Alzheimer‐type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4:97–100. [DOI] [PubMed] [Google Scholar]
  • 14.Holton JL, Ghiso J, Lashley T, Rostagno A, Guerin CJ, Gibb G, Houlden H, Ayling H, Martinian L, Anderton BH, Wood NW, Vidal R, Plant G, Frangione B, Revesz T (2001) Regional distribution of amyloid‐Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol 158:515–526. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Holtzman DM (2001) Role of apoe/Abeta interactions in the pathogenesis of Alzheimer's disease and cerebral amyloid angiopathy. J Mol Neurosci 17:147–155. [DOI] [PubMed] [Google Scholar]
  • 16.Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99–102. [DOI] [PubMed] [Google Scholar]
  • 17.Hutton M, Lewis J, Dickson D, Yen SH, McGowan E (2001) Analysis of tauopathies with transgenic mice. Trends Mol Med 7:467–470. [DOI] [PubMed] [Google Scholar]
  • 18.Janus C (2003) Vaccines for Alzheimer's disease: how close are we CNS Drugs 17:457–474. [DOI] [PubMed] [Google Scholar]
  • 19.Kim SH, Creemers JW, Chu S, Thinakaran G, Sisodia SS (2002) Proteolytic processing of familial British dementia‐associated BRI variants: evidence for enhanced intracellular accumulation of amyloidogenic peptides. J Biol Chem 277:1872–1877. [DOI] [PubMed] [Google Scholar]
  • 20.Kim SH, Wang R, Gordon DJ, Bass J, Steiner DF, Lynn DG, Thinakaran G, Meredith SC, Sisodia SS (1999) Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia. Nat Neurosci 2:984–988. [DOI] [PubMed] [Google Scholar]
  • 21.Lamb BT, Sisodia SS, Lawler AM, Slunt HH, Kitt CA, Kearns WG, Pearson PL, Price DL, Gearhart JD (1993) Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected]. Nat Genet 5:22–30. [DOI] [PubMed] [Google Scholar]
  • 22.Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293:1487–1491. [DOI] [PubMed] [Google Scholar]
  • 23.Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, van Slegtenhorst M, Gwinn‐Hardy K, Paul Murphy, M, Baker M, Yu X, Duff K, Hardy J, Corral A, Lin WL, Yen SH, Dickson DW, Davies P, Hutton M (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 25:402–405. [DOI] [PubMed] [Google Scholar]
  • 24.Lewis PA, Piper S, Baker M, Onstead L, Murphy MP, Hardy J, Wang R, McGowan E, Golde TE (2001) Expression of BRI‐amyloid beta peptide fusion proteins: a novel method for specific high‐level expression of amyloid beta peptides. Biochim Biophys Acta 1537:58–62. [DOI] [PubMed] [Google Scholar]
  • 25.Loftus SK, Erickson RP, Walkley SU, Bryant MA, Incao A, Heidenreich RA, Pavan WJ (2002) Rescue of neurodegeneration in Niemann‐Pick C mice by a prion‐promoter‐driven Npc1 cDNA trans‐gene. Hum Mol Genet 11:3107–3114. [DOI] [PubMed] [Google Scholar]
  • 26.Luthi, A. Van der Putten, H, Botteri FM, Mansuy IM, Meins M, Frey U, Sansig G, Portet C, Schmutz M, Schroder M, Nitsch C, Laurent JP, Monard D (1997) Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long‐term potentiation. JNeurosci 17:4688–4699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Malherbe P, Richards JG, Martin JR, Blueth‐mann H, Maggio J, Huber G (1996) Lack of beta‐amyloidosis in transgenic mice expressing low levels of familial Alzheimer's disease missense mutations. Neurobiol Aging 17:205–214. [DOI] [PubMed] [Google Scholar]
  • 28.McGowan E, Pickford F, Kim J, Onstead L, Er‐iksen J, Yu C, Skipper L, Murphy MP, Beard J, Das P, Jansen K, Delucia M, Lin WL, Dolios G, Wang R, Eckman CB, Dickson DW, Hutton M, Hardy J, Gol‐de T (2005) Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 47:191–199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Moechars D, Dewachter I, Lorent K, Reverse D, Baekelandt V, Naidu A, Tesseur I, Spittaels K, Haute CV, Checler F, Godaux E, Cordell B, van Leuven F (1999) Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem 274:6483–6492. [DOI] [PubMed] [Google Scholar]
  • 30.Nakayama K (1997) Furin: a mammalian sub‐tilisin/Kex2p‐like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J 327:625–635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Paleyanda RK, Drews R, Lee TK, Lubon H (1997) Secretion of human furin into mouse milk. J Biol Chem 272:15270–15274. [DOI] [PubMed] [Google Scholar]
  • 32.Phinney AL, Horne P, Yang J, Janus C, Bergeron C, Westaway D (2003) Mouse models of Alzheimer's disease: the long and filamentous road. Neurol Res 25:590–600. [DOI] [PubMed] [Google Scholar]
  • 33.Pickford F, Onstead L, Camacho‐Prihar C, Hardy J, McGowan E (2003) Expression of mBRI2 in mice. Neurosci Lett 338:95–98. [DOI] [PubMed] [Google Scholar]
  • 34.Srinivasan R, Jones EM, Liu K, Ghiso J, March‐ant RE, Zagorski MG (2003) pH‐dependent amyloid and protofibril formation by the ABri peptide of familial British dementia. J Mol Biol 333:1003–1023. [DOI] [PubMed] [Google Scholar]
  • 35.Sturchler‐Pierrat C, Abramowski D, Duke M, Wiederhold KH, Mistl C, Rothacher S, Ledermann B, Burki K, Frey P, Paganetti PA, Waridel C, Calhoun ME, Jucker M, Probst A, Staufenbiel M, Sommer B (1997) Two amyloid precursor protein transgenic mouse models with Alzheimer disease‐like pathology. Proc Natl Acad Sci USA 94:13287–13292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Thomas G (2002) Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 3:753–766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Velander WH, Page RL, Morcol T, Russell CG, Canseco R, Young JM, Drohan WN, Gwazdauskas FC, Wilkins TD, Johnson JL (1992) Production of biologically active human protein C in the milk of transgenic mice. Ann N Y Acad Sci 665:391–403. [DOI] [PubMed] [Google Scholar]
  • 38.Vidal R, Frangione B, Rostagno A, Mead S, Revesz T, Plant G, Ghiso J (1999) A stop‐codon mutation in the BRI gene associated with familial British dementia. Nature 399:776–781. [DOI] [PubMed] [Google Scholar]
  • 39.Weissmann C, Flechsig E (2003) PrP knock‐out and PrP transgenic mice in prion research. Br Med Bull 66:43–60. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES